Latest news
Annexon Reports First U.S. and European Patient Cohort of GBS FORWARD Study Demonstrated Rapid, Positive Clinical Responses in All Tanruprubart Treated Patients Within One Week - Investing News NetworkInvesting News Network · Fri, 07 Aug 2026 10:01:15 GMTAnnexon Announces Positive Clinical Outcomes from GBS FORWARD Study on Tanruprubart - Kalkine MediaKalkine Media · Thu, 06 Aug 2026 17:44:27 GMT